• loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
  • loading
    Log In
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 19
  3. 20
  4. 21
  5. 22
  6. 23
  7. …
  • Vaccine Update – Pfizer/BioNTech approved for children aged 5 to 11 years

    Qatar // 31 January, 2022

    Health authorities have approved Pfizer/BioNTech to be used in children aged 5 to 11 years...

    COVID-19

  • COVID-19 from pet hamster and onward transmission

    Hong Kong (China SAR) // 30 January, 2022

    COVID-19 transmission from hamsters to humans and onward spread

    COVID-19

  • Hypotheses of Omicron origin

    30 January, 2022

    Theories on origin of Omicron

    COVID-19

  • ECDC updates guidance on ending isolation for people with COVID-19

    29 January, 2022

    Focus on Omicron transmission and shortening isolation....

    COVID-19

  • Vaccinating parents may protect children from COVID-19

    29 January, 2022

    Parental vaccination confers protection to unvaccinated children against COVID

    COVID-19

  • Omicron Sub-Lineage BA.2 update

    Denmark // India // South Africa // United Kingdom // 28 January, 2022

    The variant is increasing in Denmark, India, South Africa and the United Kingdom....

    COVID-19

  • Higher risk of rehospitalisation and death following COVID-19 hospitalisation

    28 January, 2022

    People hospitalised due to COVID-19 are at a higher risk of rehospitalisation and death compared to general population

    COVID-19

  • COVID-19 vaccine update - Different vaccine brand as booster dose

    Nepal // 28 January, 2022

    Brand other than vero cell can be used as booster

    COVID-19

  • Third doses protect against hospitalisation

    United States // 27 January, 2022

    CDC study examines benefits of mRNA vaccine…

    COVID-19

  • European Medicines Agency recommends conditional approval for Paxlovid

    27 January, 2022

    EMA recommends conditional approval for Paxlovid...

    COVID-19

  • ECDC Assessment of the further emergence and potential impact of the SARS-CoV-2 Omicron variant of concern in the EU/EEA, 19th update

    27 January, 2022

    ECDC 19th update on SARS-CoV-2 and focus on Omicron VOC...

    COVID-19

  • Moderna begins trials for Omicron-specific booster shot

    27 January, 2022

    Moderna announced that it has begun phase two trials of a booster dose of its vaccine designed to target the Omicron variant...

    COVID-19

  • All COVID-19 restrictions to end on 31 January

    Denmark // 26 January, 2022

    COVID-19 no longer classified as “socially critical disease”…

    COVID-19

  • WHO COVID-19 Weekly Reports, January 2022

    25 January, 2022

    Summary of WHO weekly reports...

    COVID-19

  • Pfizer and BioNTech commence trial of Omicron specific vaccine

    25 January, 2022

    Pfizer and BioNTech commence variant specific vaccine trial...

    COVID-19

  • USA Food and Drug Administration revises authorisations for certain COVID-19 treatments

    United States // 25 January, 2022

    US FDA revises monocolonal antibody treatment authorisation...

    COVID-19

  • Vaccine update - Five year olds eligible for Pfizer

    Egypt // 25 January, 2022

    Pfizer vaccine is eligible for five-year-olds

    COVID-19

  • COVID-19 Updates, January 2022 - FDA limits use of some treatment options

    United States // 25 January, 2022

    Omicron now dominant, limited use of some treatment options...

    COVID-19

  • Omicron cases doubling in European Region

    24 January, 2022

    Statement from WHO Regional Director for Europe…

    COVID-19

  • Novavax approved for emergency use

    Belgium // 24 January, 2022

    First doses to arrive in February…

    COVID-19

  1. …
  2. 19
  3. 20
  4. 21
  5. 22
  6. 23
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS